Ritalin LA Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

ritalin la

novartis new zealand ltd - methylphenidate hydrochloride 40mg;   - modified release capsule - 40 mg - active: methylphenidate hydrochloride 40mg   excipient: ammonio methacrylate copolymer gelatin methacrylic acid copolymer type a -/methacryllic acid-methacrylate coplymer 1:1 dry powder iron oxide black iron oxide red iron oxide yellow macrogol 6000 purified talc sugar spheres titanium dioxide triethyl citrate - ritalin/ritalin sr is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older. ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults. ritalin/ritalin sr is indicated for the treatment of narcolepsy in adults. symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary muscle tone.

ZOLADEX LA Իսրայել - անգլերեն - Ministry of Health

zoladex la

astrazeneca (israel) ltd - goserelin as acetate - implant for injection - goserelin as acetate 10.8 mg/unit - goserelin - goserelin - prostate cancer suitable for hormonal manipulation.

Bimoxyvet LA 150 mg/ml, Suspension for Injection for cattle, sheep and pigs Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

bimoxyvet la 150 mg/ml, suspension for injection for cattle, sheep and pigs

laboratorios maymó, s.a. - amoxicillin trihydrate - suspension for injection - 150 milligram(s)/millilitre - amoxicillin - cattle, pigs, sheep - antibacterial

Maxoject LA 200 mg/ml Solution for Injection Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

maxoject la 200 mg/ml solution for injection

chem-pharm limited - oxytetracycline - solution for injection - 200 milligram(s)/millilitre - oxytetracycline - cattle, pigs, sheep - antibacterial

Promox LA 150 mg/ml Suspension for Injection Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

promox la 150 mg/ml suspension for injection

interchem ireland ltd - amoxicillin trihydrate - suspension for injection - 150 milligram(s)/millilitre - amoxicillin - cattle, pigs, sheep - antibacterial

Ritalin LA Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

ritalin la

novartis new zealand ltd - methylphenidate hydrochloride 60mg;   - modified release capsule - 60 mg - active: methylphenidate hydrochloride 60mg   excipient: ammonio methacrylate copolymer gelatin iron oxide black iron oxide red iron oxide yellow macrogol 6000 methacrylic acid copolymer purified talc sugar spheres tekprint tan sw-8010 titanium dioxide triethyl citrate - ritalin la is indicated in the treatment of attention-deficit/hyperactivity disorder in children aged 6 years or older and in adults.

RITALIN LA- methylphenidate hydrochloride capsule, extended release Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

ritalin la- methylphenidate hydrochloride capsule, extended release

novartis pharmaceuticals corporation - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 20 mg - ritalin la® is indicated for the treatment of attention deficit hyperactivity disorder (adhd), in pediatric patients 6 to 12 years of age [see clinical studies (14)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to adhd medications, including ritalin la during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for adhd medications at 1-866-961-2388 or visiting https://womensmentalhealth.org/adhd-medications/. risk summary published studies and postmarketing reports on methylphenidate use during pregnancy have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there may be risks to the fetus associated with the use of cns stimulants use during pregnancy (see clinical considerations) . no effects on morphological development were observed in embryo-fetal development studies with oral administration of methylphenidate t